1. Home >
  2. M&A >
  3. IPO >
  4. United States >
  5. Texas >
  6. CD&R Exits agilon health

Investment Summary

CD&R Exits agilon health

On April 14, 2021, invested in healthcare services company agilon health from CD&R

Investment Highlights
  • This is transaction in the Healthcare Services sector.
  • This is transaction in the United States.
  • This is transaction in Texas.

Investment Summary
Date 2021-04-14
Target agilon health
Sector Healthcare Services
Sellers(s) CD&R
Deal Type IPO

Target

agilon health

Austin, Texas, United States
agilon health serves as a partner to physicians and other providers so that they can be more productive and effective in providing high-quality, value-based care. The company’s unique mix of technology-based services and clinical capabilities supports physicians serving a diverse mix of patients across multiple geographies, with differentiated expertise managing underserved Medicaid and Medicare Advantage patients. agilon health was incorporated in 2016 and is headquartered in Austin, Texas.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Seller(S) 1

SELLER

CD&R

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1978
PE ASSETS 30.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Clayton, Dubilier & Rice LLC (CD&R) is a large private equity firm that targets non-core divestitures of large corporations, growth equity financings, traditional buyouts, and corporate/family partnerships. CD&R looks for opportunities in North America, Western Europe, and Asia and will consider businesses in a wide range of sectors including consumer/retail, healthcare, industrials, and services. Prospective companies generally lead their respective markets, have stable cash flows, and possess competitive advantages through differentiated products, services, or processes. CD&R was formed in 1978 and has offices in New York City and London.

DEAL STATS #
Overall 40 of 48
Sector: Healthcare Services M&A 4 of 4
Type: IPO M&A Deals 17 of 18
State: Texas M&A 4 of 5
Country: United States M&A 30 of 38
Year: 2021 M&A 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-17 Aster Insights

Tampa, Florida, United States

Aster Insights is an oncology-focused health informatics solutions company that leverages clinical and molecular data to accelerate the discovery, development, and delivery of personalized therapies. Founded in 2006 with a mission to enable a collaborative approach to the fight against cancer, Aster Insights facilitates the Oncology Research Information Exchange Network (ORIEN), an alliance of leading cancer centers that participate in the HIPAA-compliant, IRB-approved protocol, Total Cancer Care, to gather de-identified clinical and genomic patient data for research purposes. Aster Insights was founded in 2006 and is based in Tampa, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-12 UDG Healthcare

Dublin, Ireland

UDG Healthcare operates in two segments, Ashfield and Sharp. Ashfield is a global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement, and patient solutions. Sharp engages in contract packaging, clinical, manufacturing, and technology services. UDG Healthcare was founded in 1948 and is based in Dublin, the Republic of Ireland.

Buy $3.7B
Mergr

Solution for

Product

Company

Legal